作为潜在的抗瘤剂的基纳索林衍生物:诱导细胞死亡的结构特征和分子机制 (综述)
Jianqin Li1, Yan Yang1, Lei Wang1
1Oncology Department, The First Affiliated Hospital, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
International journal of molecular medicine
|September 26, 2025
概括
基纳索林衍生物通过向多个细胞死亡途径,显示出其作为抗瘤剂的前景. 本综述探讨了它们的机制和癌症药物发现的临床潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 奎纳佐利诺支架是天然产品和类化合物的关键结构图案.
- 它的结构多功能性有利于开发新的抗癌疗法.
- 基纳索林可以调节各种编程细胞死亡途径.
研究的目的:
- 系统地审查纳佐利诺诱导的瘤细胞死亡的分子机制.
- 批判性地评估quinazolinone衍生物的临床翻译潜力.
- 总结一下已批准的和正在研究的基于quinazolinone的抗癌药物.
主要方法:
- 关于quinazolinone衍生物及其抗癌性能的文献综述.
- 对导致瘤细胞死亡的分子机制的分析.
- 评估临床试验数据和临床前发展状态.
主要成果:
- 基纳索林衍生物有效诱导多种细胞死亡模式 (细胞亡,自,铁亡,衰老,热亡,亡).
- 有针对性的化学修饰允许精确的药理学调制.
- 几种基于quinazolinone的药物已获得FDA批准或处于临床前开发阶段.
结论:
- 基纳索林为针对性抗癌药物发现提供了一个有前途的支架.
- 了解它们的作用机制可以指导新瘤疗法的开发.
- 基于quinazolinone的抗瘤药物需要进一步的研究和临床转化.
相关概念视频
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Overview of Cell Death
9.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
814
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
814
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


